search
Back to results

Assessment of the Effects of Early Proprioceptive Stimulations in Patients With Severe Traumatic Brain Injury (TC-Mouv)

Primary Purpose

Traumatic Brain Injuries

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Proprioceptive stimulations
Sham stimulations
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Traumatic Brain Injuries focused on measuring traumatic brain injuries, proprioceptive stimulation, vibration, spasticity, intensive care units

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Severe TBI : Glasgow coma score (GCS) ≤ 8 (11)
  • Age ≥ 18 years old
  • No pregnancy
  • Not being under guardianship
  • Be affiliated to the French social security system

Exclusion Criteria:

  • Orthopedic lesions or any medical condition that prevent the implementation of the protocol within ten days post-injury
  • Traumatic SCI

Sites / Locations

  • Bicêtre HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Intervention group

Control group

Arm Description

Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement.

Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations.

Outcomes

Primary Outcome Measures

Changes in the modified Ashworth scale (MAS)
The MAS enables to assess spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity) adductors and gracilis
Changes in the angles of the muscle reaction in the modified Tardieu scale (MTS)
The MTS enables to assess the severity of spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (The outcome is reported in degree, from 0 to 180 degrees, higher values represent a higher dynamic component of spasticity)
Changes in the quality of the muscle reaction in the modified Tardieu scale (MTS)
The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity)
Changes in the Spinal cord assessment tool for spastic reflexes (SCATS)
This score enables to asses global spasticity (Score range from 0 to 18, higher values represent a higher degree of spasticity)

Secondary Outcome Measures

Changes in the visual analog scale for the auto-assessment of problematic spasticity
Score range from 0 to 100, higher values represent a higher degree of problematic spasticity.
Changes in the visual analog scale for the auto-assessment of problematic spasticity
Score range from 0 to 100, higher values represent a higher degree of problematic spasticity.
Changes in the Coma recovery scale-revised (CRS-R)
This measure enables to assess coma recovery (Score range from 0 to 23, higher values represent a better outcome)
Changes in the Glasgow outcome scale (GOS)
This measure enables to assess coma recovery (Score range from 0 to 5, higher values represent a better outcome)
Changes in the Glasgow outcome scale-extended (GOS-E)
This measure enables to assess coma recovery (Score range from 0 to 8, higher values represent a better outcome)
Changes in the Disability rating scale (DRS)
This measure enables to assess coma recovery (Score range from 0 to 29, lower values represent a better outcome)
Changes in the quadriceps muscle thickness
"Measured with ultrasound, average of two measures (at the border between the lower third and upper two-thirds between the anterior superior iliac spine and the upper pole of the patella, and at the midpoint between the anterior superior iliac spine and the upper pole of the patella) (Measure in centimeters, higher values represent a better outcome)"
Changes in the Montreal cognitive assessment (MoCA)
This measure enables to assess cognitive impairments (Score range from 0 to 30, higher values represent a better outcome)
Changes in the time to complete the bells cancellation test to assess cognitive impairments
This measure enables to assess cognitive impairments (Measure in minutes and seconds, lower values represent a better outcome)
Changes in the digit span test to assess cognitive impairments
This measure enables to assess cognitive impairments (Higher values represent a better outcome)
Changes in the Posttraumatic stress disorder checklist scale (PCLS) to assess cognitive impairments
This measure enables to assess cognitive impairments (Score range from 17 to 85, lower values represent a better outcome)
Changes in the Hospital anxiety and depression scale (HAD scale)
This measure enables to assess cognitive impairments (Score range from 0 to 42, lower values represent a better outcome)

Full Information

First Posted
September 22, 2021
Last Updated
October 15, 2021
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT05094999
Brief Title
Assessment of the Effects of Early Proprioceptive Stimulations in Patients With Severe Traumatic Brain Injury
Acronym
TC-Mouv
Official Title
Assessment of the Effects of Early Proprioceptive Stimulations in Patients With Severe Traumatic Brain Injury : a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Recruiting
Study Start Date
October 20, 2021 (Anticipated)
Primary Completion Date
September 20, 2024 (Anticipated)
Study Completion Date
September 20, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
"Severe traumatic brain injury (TBI) is a serious condition, common in young adults. It leads to sensorimotor and cognitive sequelae that hinder social reintegration. Neuronal plasticity must be used quickly before natural recovery impedes neuronal regrowth. In this respect, stopping sedation as soon as possible and early mobilization, even if the patients are unconscious, are recognized as useful measures to promote recovery. However, at the early stage, the environment of the ICU and the acute condition of the patients limit the rehabilitation possibilities. In such a context, functional proprioceptive stimulations (Vibramoov™ system, Techno Concept, France) could be a tool of interest. By using the proprioceptive signatures of cyclic movements, proprioceptive stimulations can elicit the illusion of these movements. A motor response can even be obtained through the interactions between the peripheral nervous system and the central nervous system. Finally, such stimulations facilitate the initiation of the mimicked movements. Some studies have already shown the benefits of proprioceptive vibrations. However, so far, these benefits have only been studied at the chronic stage of neurological diseases. The investigators hypothesized that early functional proprioceptive stimulations (FPS) may reduce spasticity and promote recovery in patients with severe traumatic brain injury. To test the hypothesis, the investigators conduct a randomized controlled trial on patients with severe traumatic brain injury. Every patient will be included as soon as possible in the ICU and receive either FPS, either sham stimulations to the joints of the lower limbs, 4 times a week during 8 weeks. The primary outcome measures will assess spasticity. The investigators also assess pain, coma recovery; muscle wasting and cognitive impairments. "

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Traumatic Brain Injuries
Keywords
traumatic brain injuries, proprioceptive stimulation, vibration, spasticity, intensive care units

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement.
Arm Title
Control group
Arm Type
Sham Comparator
Arm Description
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations.
Intervention Type
Device
Intervention Name(s)
Proprioceptive stimulations
Intervention Description
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement.
Intervention Type
Device
Intervention Name(s)
Sham stimulations
Intervention Description
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations.
Primary Outcome Measure Information:
Title
Changes in the modified Ashworth scale (MAS)
Description
The MAS enables to assess spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity) adductors and gracilis
Time Frame
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Title
Changes in the angles of the muscle reaction in the modified Tardieu scale (MTS)
Description
The MTS enables to assess the severity of spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (The outcome is reported in degree, from 0 to 180 degrees, higher values represent a higher dynamic component of spasticity)
Time Frame
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Title
Changes in the quality of the muscle reaction in the modified Tardieu scale (MTS)
Description
The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity)
Time Frame
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Title
Changes in the Spinal cord assessment tool for spastic reflexes (SCATS)
Description
This score enables to asses global spasticity (Score range from 0 to 18, higher values represent a higher degree of spasticity)
Time Frame
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Secondary Outcome Measure Information:
Title
Changes in the visual analog scale for the auto-assessment of problematic spasticity
Description
Score range from 0 to 100, higher values represent a higher degree of problematic spasticity.
Time Frame
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Title
Changes in the visual analog scale for the auto-assessment of problematic spasticity
Description
Score range from 0 to 100, higher values represent a higher degree of problematic spasticity.
Time Frame
Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury
Title
Changes in the Coma recovery scale-revised (CRS-R)
Description
This measure enables to assess coma recovery (Score range from 0 to 23, higher values represent a better outcome)
Time Frame
At inclusion, and at one month, 2 months and 1 year after the injury.
Title
Changes in the Glasgow outcome scale (GOS)
Description
This measure enables to assess coma recovery (Score range from 0 to 5, higher values represent a better outcome)
Time Frame
At inclusion, and at one month, 2 months and 1 year after the injury.
Title
Changes in the Glasgow outcome scale-extended (GOS-E)
Description
This measure enables to assess coma recovery (Score range from 0 to 8, higher values represent a better outcome)
Time Frame
At inclusion, and at one month, 2 months and 1 year after the injury.
Title
Changes in the Disability rating scale (DRS)
Description
This measure enables to assess coma recovery (Score range from 0 to 29, lower values represent a better outcome)
Time Frame
At inclusion, and at one month, 2 months and 1 year after the injury.
Title
Changes in the quadriceps muscle thickness
Description
"Measured with ultrasound, average of two measures (at the border between the lower third and upper two-thirds between the anterior superior iliac spine and the upper pole of the patella, and at the midpoint between the anterior superior iliac spine and the upper pole of the patella) (Measure in centimeters, higher values represent a better outcome)"
Time Frame
At inclusion, then once a week during the first month, and at 2 months, 6 months and 1 year after the injury
Title
Changes in the Montreal cognitive assessment (MoCA)
Description
This measure enables to assess cognitive impairments (Score range from 0 to 30, higher values represent a better outcome)
Time Frame
Up to 1 month, then at 2 months and 1 year after the injury
Title
Changes in the time to complete the bells cancellation test to assess cognitive impairments
Description
This measure enables to assess cognitive impairments (Measure in minutes and seconds, lower values represent a better outcome)
Time Frame
Up to 1 month, then at 2 months and 1 year after the injury
Title
Changes in the digit span test to assess cognitive impairments
Description
This measure enables to assess cognitive impairments (Higher values represent a better outcome)
Time Frame
Up to 1 month, then at 2 months and 1 year after the injury
Title
Changes in the Posttraumatic stress disorder checklist scale (PCLS) to assess cognitive impairments
Description
This measure enables to assess cognitive impairments (Score range from 17 to 85, lower values represent a better outcome)
Time Frame
Up to 1 month, then at 2 months and 1 year after the injury
Title
Changes in the Hospital anxiety and depression scale (HAD scale)
Description
This measure enables to assess cognitive impairments (Score range from 0 to 42, lower values represent a better outcome)
Time Frame
Up to 1 month, then at 2 months and 1 year after the injury

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Severe TBI : Glasgow coma score (GCS) ≤ 8 (11) Age ≥ 18 years old No pregnancy Not being under guardianship Be affiliated to the French social security system Exclusion Criteria: Orthopedic lesions or any medical condition that prevent the implementation of the protocol within ten days post-injury Traumatic SCI
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bernard VIGUE
Phone
0033145216310
Email
bernard.vigue@aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bernard VIGUE
Organizational Affiliation
APHP
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bicêtre Hospital
City
Le Kremlin-Bicêtre
ZIP/Postal Code
94270
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bernard Vigué, MD PhD
Phone
0033145216310
Email
bernard.vigue@aphp.fr
First Name & Middle Initial & Last Name & Degree
Bernard Vigué, MD PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Assessment of the Effects of Early Proprioceptive Stimulations in Patients With Severe Traumatic Brain Injury

We'll reach out to this number within 24 hrs